Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A0A3Q8ILA3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 165 | 167 | PF00675 | 0.599 |
CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.705 |
CLV_NRD_NRD_1 | 275 | 277 | PF00675 | 0.360 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.470 |
CLV_NRD_NRD_1 | 63 | 65 | PF00675 | 0.645 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.635 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.705 |
CLV_PCSK_KEX2_1 | 277 | 279 | PF00082 | 0.440 |
CLV_PCSK_KEX2_1 | 47 | 49 | PF00082 | 0.469 |
CLV_PCSK_KEX2_1 | 63 | 65 | PF00082 | 0.645 |
CLV_PCSK_PC1ET2_1 | 132 | 134 | PF00082 | 0.528 |
CLV_PCSK_PC1ET2_1 | 163 | 165 | PF00082 | 0.560 |
CLV_PCSK_PC1ET2_1 | 277 | 279 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 203 | 207 | PF00082 | 0.511 |
CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.641 |
DEG_SPOP_SBC_1 | 12 | 16 | PF00917 | 0.434 |
DOC_MAPK_MEF2A_6 | 143 | 150 | PF00069 | 0.421 |
DOC_PP4_FxxP_1 | 77 | 80 | PF00568 | 0.629 |
DOC_USP7_MATH_1 | 11 | 15 | PF00917 | 0.437 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.637 |
DOC_USP7_MATH_1 | 238 | 242 | PF00917 | 0.456 |
DOC_USP7_MATH_1 | 301 | 305 | PF00917 | 0.730 |
DOC_WW_Pin1_4 | 296 | 301 | PF00397 | 0.715 |
LIG_14-3-3_CanoR_1 | 126 | 136 | PF00244 | 0.581 |
LIG_14-3-3_CanoR_1 | 292 | 297 | PF00244 | 0.592 |
LIG_BRCT_BRCA1_1 | 287 | 291 | PF00533 | 0.553 |
LIG_BRCT_BRCA1_1 | 292 | 296 | PF00533 | 0.657 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.625 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.642 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.444 |
LIG_FHA_2 | 172 | 178 | PF00498 | 0.682 |
LIG_FHA_2 | 68 | 74 | PF00498 | 0.631 |
LIG_IBAR_NPY_1 | 285 | 287 | PF08397 | 0.534 |
LIG_LIR_Apic_2 | 210 | 216 | PF02991 | 0.506 |
LIG_LIR_Gen_1 | 106 | 116 | PF02991 | 0.647 |
LIG_LIR_Nem_3 | 261 | 266 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 32 | 38 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 86 | 92 | PF02991 | 0.645 |
LIG_PDZ_Class_1 | 301 | 306 | PF00595 | 0.491 |
LIG_SH2_CRK | 217 | 221 | PF00017 | 0.510 |
LIG_SH2_CRK | 287 | 291 | PF00017 | 0.486 |
LIG_SH2_NCK_1 | 287 | 291 | PF00017 | 0.486 |
LIG_SH2_PTP2 | 213 | 216 | PF00017 | 0.505 |
LIG_SH2_STAP1 | 287 | 291 | PF00017 | 0.553 |
LIG_SH2_STAT3 | 246 | 249 | PF00017 | 0.516 |
LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.530 |
LIG_SH3_3 | 33 | 39 | PF00018 | 0.530 |
LIG_SUMO_SIM_par_1 | 267 | 272 | PF11976 | 0.551 |
LIG_TYR_ITSM | 85 | 92 | PF00017 | 0.599 |
LIG_WW_3 | 299 | 303 | PF00397 | 0.565 |
MOD_CDK_SPxK_1 | 296 | 302 | PF00069 | 0.566 |
MOD_CK2_1 | 171 | 177 | PF00069 | 0.677 |
MOD_CK2_1 | 222 | 228 | PF00069 | 0.519 |
MOD_CK2_1 | 67 | 73 | PF00069 | 0.626 |
MOD_Cter_Amidation | 19 | 22 | PF01082 | 0.560 |
MOD_Cter_Amidation | 61 | 64 | PF01082 | 0.663 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.591 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.504 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.623 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.568 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.663 |
MOD_GSK3_1 | 286 | 293 | PF00069 | 0.547 |
MOD_GSK3_1 | 296 | 303 | PF00069 | 0.686 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.561 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.570 |
MOD_N-GLC_1 | 223 | 228 | PF02516 | 0.523 |
MOD_N-GLC_1 | 82 | 87 | PF02516 | 0.665 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.583 |
MOD_NEK2_1 | 111 | 116 | PF00069 | 0.619 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.563 |
MOD_NEK2_1 | 245 | 250 | PF00069 | 0.470 |
MOD_NEK2_1 | 255 | 260 | PF00069 | 0.374 |
MOD_NEK2_1 | 291 | 296 | PF00069 | 0.705 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.664 |
MOD_NEK2_2 | 286 | 291 | PF00069 | 0.557 |
MOD_PIKK_1 | 245 | 251 | PF00454 | 0.587 |
MOD_PKA_1 | 132 | 138 | PF00069 | 0.521 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.628 |
MOD_PKA_2 | 207 | 213 | PF00069 | 0.672 |
MOD_PKA_2 | 291 | 297 | PF00069 | 0.507 |
MOD_Plk_1 | 223 | 229 | PF00069 | 0.492 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.424 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.643 |
MOD_Plk_4 | 146 | 152 | PF00069 | 0.540 |
MOD_Plk_4 | 238 | 244 | PF00069 | 0.566 |
MOD_Plk_4 | 286 | 292 | PF00069 | 0.564 |
MOD_ProDKin_1 | 296 | 302 | PF00069 | 0.719 |
MOD_SUMO_rev_2 | 190 | 197 | PF00179 | 0.626 |
MOD_SUMO_rev_2 | 280 | 284 | PF00179 | 0.491 |
TRG_DiLeu_BaEn_2 | 49 | 55 | PF01217 | 0.538 |
TRG_ENDOCYTIC_2 | 217 | 220 | PF00928 | 0.557 |
TRG_ENDOCYTIC_2 | 287 | 290 | PF00928 | 0.481 |
TRG_ENDOCYTIC_2 | 89 | 92 | PF00928 | 0.671 |
TRG_ER_diArg_1 | 164 | 166 | PF00400 | 0.638 |
TRG_ER_diArg_1 | 21 | 23 | PF00400 | 0.691 |
TRG_ER_diArg_1 | 275 | 278 | PF00400 | 0.361 |
TRG_ER_diArg_1 | 46 | 49 | PF00400 | 0.462 |
TRG_Pf-PMV_PEXEL_1 | 53 | 58 | PF00026 | 0.550 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAU8 | Leptomonas seymouri | 59% | 100% |
A0A0S4IYA0 | Bodo saltans | 24% | 100% |
A0A1X0PA38 | Trypanosomatidae | 29% | 100% |
A0A3R7KSA4 | Trypanosoma rangeli | 31% | 100% |
A4HB13 | Leishmania braziliensis | 73% | 100% |
A4IA70 | Leishmania infantum | 100% | 100% |
C9ZM36 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
E9B583 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q2Q0 | Leishmania major | 90% | 100% |
V5BV16 | Trypanosoma cruzi | 31% | 100% |